 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || m-ceNK cells / ImmunityBio
Enrollment change, Trial completion date, Trial primary completion date, Metastases: QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Jun 18, 2023
P1, N=50, Recruiting, Sponsor: ImmunityBio, Inc.
N=30 --> 50 | Trial completion date: Jun 2022 --> Dec 2024 | Trial primary completion date: Jun 2022 --> Jun 2024
- || m-ceNK cells / ImmunityBio
Enrollment open, Metastases: QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Jul 26, 2021
P1, N=30, Recruiting, Sponsor: ImmunityBio, Inc.
N=30 --> 50 | Trial completion date: Jun 2022 --> Dec 2024 | Trial primary completion date: Jun 2022 --> Jun 2024 Not yet recruiting --> Recruiting
- || m-ceNK cells / ImmunityBio
New P1 trial, Metastases: QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - May 24, 2021
P1, N=30, Not yet recruiting, Sponsor: ImmunityBio, Inc.